What is NDC 68788-7742?

68788-7742 is the product NDC for Lansoprazole, Lansoprazole 30 mg/1 capsule, delayed release, listed with the FDA by Preferred Pharmaceuticals, Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.

Preferred Pharmaceuticals, Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lansoprazole?

94 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lansoprazole NDC 68788-7742 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68788-7742Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68788-7742Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68788-7742-1	6878877420168788774201	14 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-7742-1)Marketed from Jul 1, 2020
68788-7742-3	6878877420368788774203	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-7742-3)Marketed from Jul 1, 2020
68788-7742-6	6878877420668788774206	60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-7742-6)Marketed from Jul 1, 2020
68788-7742-8	6878877420868788774208	120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-7742-8)Marketed from Jul 1, 2020
68788-7742-9	6878877420968788774209	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-7742-9)Marketed from Jul 1, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lansoprazole
Generic name (nonproprietary): lansoprazole
Active ingredients: Lansoprazole — 30 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Preferred Pharmaceuticals, Inc.NDC labeler code 68788
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205868
Marketing start: Jul 1, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Inhibition Gastric Acid Secretion (Physiologic effect)Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 68788-7742_e4bb76ca-2202-43b5-be9a-3767ef0df6d0SPL ID e4bb76ca-2202-43b5-be9a-3767ef0df6d0SPL set ID 7286d6a5-611b-4993-ab93-4899d599435dRxCUI 311277UNII 0K5C5T2QPG
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788774201 followed by a unit qualifier and the quantity

Package 68788-7742-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 18, 2026.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Lansoprazole delayed-release capsules are proton pump inhibitors (PPIs) indicated for the: • Treatment of active duodenal ulcer in adults( 1.1 ) • Eradication of H. pylori to reduce the risk of duodenal ulcer recurrence in adults ( 1.2 ) • Maintenance of healed duodenal ulcers in adults ( 1.3 ) • Treatment of active benign gastric ulcer in adults ( 1.4 ) • Healing of non-steroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults ( 1.5 ) • Risk reduction of NSAID-associated gastric ulcer in adults( 1.6 ) • Treatment of symptomatic gastroesophageal reflux disease (GERD) in adults and pediatric patients 1 year of age and older ( 1.7 ) • Treatment of er…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68788-7742

What is NDC 68788-7742?: 68788-7742 is the product NDC for Lansoprazole, Lansoprazole 30 mg/1 capsule, delayed release, listed with the FDA by Preferred Pharmaceuticals, Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lansoprazole.
What is the active ingredient?: Lansoprazole.
Who is the labeler?: Preferred Pharmaceuticals, Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lansoprazole?: 94 other product NDCs are listed under this name. See all Lansoprazole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lansoprazole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lansoprazole	Lansoprazole 30 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Cardinal Health 107, LLC	55154-8340	55154-8340-00
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Amazon.com Services LLC	72288-672	72288-0672-55
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed release pelletsOral	Preferred Pharmaceuticals Inc.	68788-4141	68788-4141-0368788-4141-0668788-4141-09
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Amazon.com Services LLC	72288-827	72288-0827-03
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed release pelletsOral	Safecor Health LLC	48433-051	48433-0051-08
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Medcore LLC	82461-713	82461-0713-30
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-311	33342-0311-07
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-310	33342-0310-07
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Preferred Pharmaceuticals Inc.	68788-8621	68788-8621-0168788-8621-0368788-8621-06+2 more
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	NorthStar Rx LLC	72603-313	72603-0313-10

All 95 Lansoprazole NDCs

Other NDCs under ANDA 205868

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205868
Product	Strength	Form · route	Labeler	Product NDC
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	A-S Medication Solutions	50090-6079
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-2274
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-3633
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-5119
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Lifestar Pharma LLC.	70756-806
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Lifestar Pharma LLC.	70756-807
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Bryant Ranch Prepack	71335-1425
Lansoprazole DR	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Direct_Rx	72189-370
Lansoprazole DRlansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0174